Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and the largest sequencing capacity in the world.
Novogene delivers unsurpassed data quality to support our customers’research goals. We are a world-leader in NGS services, with thousands of employees and multiple locations across the globe. Novogene has strong scientific expertise and experience with 37 NGS-related patents, as well as over 670 research papers with total impact factor at more than 4930, including publications in first tiers journals such as Cell, Nature and Science.
As the largest NGS service provider headquartered in Beijing with branches in Hong Kong China, US, UK, Singapore, Netherlands, Japan and Thailand, Novogene was founded in 2011 and has been growing rapidly over the past few years. Novogene has genomic sequencing labs in the US (at The University of California at Davis campus), China, Singapore, and the UK (Cambridge).
Advancing Genomics, Improving Life
To be the Global Leader in Providing Genomic Services and Solutions
Professionalism, Innovation, Integrity, Partnership
Company founder, Dr. Ruiqiang Li
Dr. Ruiqiang Li, is widely recognized as one of the world’s leading experts in genomics and bioinformatics, has applied for 35 patents and authored over 100 publications that have been cited more than 42,000 times. Best known for developing the software SOAP (Short Oligonucleotide Analysis Package) for ultra-fast sequence mapping, variation detection, and de novo genome assembly, Dr. Li has focused the company on being a full-service provider, performing NGS services and providing bioinformatic analysis to fully empower and enable our customers to move forward rapidly and effectively in their scientific endeavors.